IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 2, 2008, Pages 186-190

  Araújo, Flábio R ^a   Costa, Cátia M ^b   Ramos, Carlos A N ^c   Farias, Thais A ^a   De Souza, Ingrid Ieda F ^a   Melo, Elaine S P ^c   Elisei, Carina ^a   Rosinha, Gracia M S ^a   Soares, Cleber O ^a   Fragoso, Stênio P ^d   Fonseca, Adivaldo H ^b  

^a EMBRAPA CERRADOS   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^d Instituto de Biologia Molecular do Parana   (Brazil)

Author keywords

Anaplasma marginale; Cattle; Elongation factor; Recombinant proteins; Tu; Vaccine; VirB

Indexed keywords

ANAPLASMA MARGINALE; BACTERIA (MICROORGANISMS); BOS; BOVIDAE; NEGIBACTERIA; RICKETTSIA;

EID: 42149112817     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762008000200010     Document Type: Article

References (25)

1. Ajayi SA, Wilson AJ, Campbell RS 1978. Experimental bovine anaplasmosis: clinico-pathological and nutritional studies. Res Vet Sci 25: 76-81.
2. Barbet AF, Palmer GH, Myler PJ, McGuire TC 1987. Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide Am105L. Infect Immun 55: 2428-2435.
3. Barros SL, Madruga CR, Araújo FR, Menk CF, de Almeida MA, Melo EP, Kessler RH 2005. Serological survey of Babesia bovis, Babesia bigemina, and Anaplasma marginale antibodies in cattle from the semi-arid region of the state of Bahia, Brazil, by enzyme-linked immunosorbent assays. Mem Inst Oswaldo Cruz 100: 513-517.
4. Brayton KA, Kappmeyer LS, Herndon DR, Dark MJ, Tibbals DL, Palmer GH, McGuire TC, Knowles DP Jr 2005. Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc Natl Acad Sci USA 102: 844-849.
5. Brayton KA, Palmer GH, Brown WC 2006. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale. Expert Rev Vaccines 5: 95-101.
6. Brown WC, Palmer GH, Lewin HA, McGuire TC 2001. CD4+ T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains. Infect Immun 69: 6853-6862.
7. Brown WC, Shkap V, Zhu D, McGuire TC, Tuo W, McElwain TF, Palmer GH 1998. CD4+ T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect Immun 66: 5406-5413.
8. Correa WM, Correa CN, Gottschalk AF 1978. Bovine abortion associated with Anaplasma marginale. Can J Comp Med 42: 227-228.
9. Dumler JS, Barbet AF, Bekker CP, Dasch GA, Palmer GH, Ray SC, Rikihisa Y, Rurangirwa FR 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 51: 2145-2165.
10. Frey A, Di Canzio J, Zurakowski D 1998. A statistically defined end-point titer determination method for immunoassays. J Immunol Methods 221: 35-41.
11. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthe'sy-Theulaz IE 2004. Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72: 2160-2169.
12. Kocan KM, de la Fuente J, Guglielmone AA, Melendez RD 2003. Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 16: 698-712.
13. Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE, Brown WC 2007. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect Immun 75: 2333-2342.
14. Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J, Brown WC 2005. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73: 8109-8118.
15. Melo ESP, Araújo FR, Ramos CAN, Soares CO, Rosinha GMS, Elisei C, Madruga CR 2007. ELISA com MSP5 recombinante truncada para detecção de anticorpos contra Anaplasma marginale em bovinos bovinos. Pesq Vet Bras 27: 301-306.
16. Montenegro-James S, James MA, Benitez MT, Leon E, Baek BK, Guillen AT 1991. Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis. Parasitol Res 77: 93-101.
17. Nilsson J, Nissen P 2005. Elongation factors on the ribosome. Curr Opin Struct Biol 15: 349-354.
18. Oberle SM, Barbet AF 1993. Derivation of the complete msp4 gene sequence of Anaplasma marginale without cloning. Gene 136: 291-294.
19. Oberle SM, Palmer GH, Barbet AF, McGuire TC 1988. Molecular size variations in an immunoprotective protein complex among isolates of Anaplasma marginale. Infect Immun 56: 1567-1573.
20. Palmer GH, Barbet AF, Kuttler KL, McGuire TC 1986. Detection of an Anaplasma marginale common surface protein present in all stages of infection. J Clin Microbiol 23: 1078-1083.
21. Palmer GH, McGuire TC 1984. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J Immunol 133: 1010-1015.
22. Palmer GH, Rurangirwa FR, Kocan KM, Brown WC 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol Today 15: 281-286.
23. Rodriguez SD, Garcia Ortiz MA, Hernandez Salgado G, Santos Cerda NA, Aboytes Torre R, Canto Alarcon GJ 2000. Anaplasma marginale inactivated vaccine: dose titration against a homologous challenge. Comp Immunol Microbiol Infect Dis 23: 239-252.
24. Silva VM, Araújo FR, Madruga CR, Soares CO, Kessler RH, Almeida MA, Fragoso SP, Santos LR, Ramos CA, Bacanelli G, Torres RA 2006. Comparison between indirect enzyme-linked immunosorbent assays for Anaplasma marginale antibodies with recombinant major surface protein 5 and initial body antigens. Mem Inst Oswaldo Cruz 101: 511-516.
25. Tebele N, McGuire TC, Palmer GH 1991. Induction of protective immunity by using Anaplasma marginale initial body membranes. Infect Immun 59: 3199-3204.